Lack of significant viral load alterations of hepatitis B virus and hepatitis C virus during treatment with IL-2 and highly active antiretroviral therapy

U. R. Hengge; M. Roggendorf; M. Goos

doi:10.1097/00002030-200011100-00030

Lack of significant viral load alterations of hepatitis B virus and hepatitis C virus during treatment with IL-2 and highly active antiretroviral therapy

U. R. Hengge
, M. Roggendorf
, M. Goos

University of Duisburg-Essen

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Original language	English
Pages (from-to)	2617-2619
Number of pages	3
Journal	AIDS
Volume	14
Issue number	16
DOIs	https://doi.org/10.1097/00002030-200011100-00030
State	Published - 2000
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1097/00002030-200011100-00030

Cite this

@article{ab2c891bfccf4c52acfbbfac87fc6119,

title = "Lack of significant viral load alterations of hepatitis B virus and hepatitis C virus during treatment with IL-2 and highly active antiretroviral therapy",

author = "Hengge, \{U. R.\} and M. Roggendorf and M. Goos",

year = "2000",

doi = "10.1097/00002030-200011100-00030",

language = "English",

volume = "14",

pages = "2617--2619",

journal = "AIDS",

issn = "0269-9370",

publisher = "Lippincott Williams and Wilkins",

number = "16",

}

TY - JOUR

T1 - Lack of significant viral load alterations of hepatitis B virus and hepatitis C virus during treatment with IL-2 and highly active antiretroviral therapy

AU - Hengge, U. R.

AU - Roggendorf, M.

AU - Goos, M.

PY - 2000

Y1 - 2000

UR - https://www.scopus.com/pages/publications/0033747377

U2 - 10.1097/00002030-200011100-00030

DO - 10.1097/00002030-200011100-00030

M3 - Article

C2 - 11101079

AN - SCOPUS:0033747377

SN - 0269-9370

VL - 14

SP - 2617

EP - 2619

JO - AIDS

JF - AIDS

IS - 16

ER -

Lack of significant viral load alterations of hepatitis B virus and hepatitis C virus during treatment with IL-2 and highly active antiretroviral therapy

UN SDGs

Access to Document

Other files and links

Cite this